Lyra TherapeuticsLYRA
13F holders, Q2 2025 (June 30)1holders −56
1new positions
35sold out
$0.09avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Lyra Therapeutics Inc. (LYRA) in their 13F filings, down 56 from Q1 2025. 1 opened new positions and 35 sold out. The largest holder was IFP Advisors, Inc ($26).
- Company
- Lyra Therapeutics Inc.
- CUSIP
- 55234L105
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $26 |
| Exits | 35 | $622K |
All 13F filers, Q1 2025 → Q2 2025: 300 shares bought and 4,917,130 shares sold, net −4,916,830 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | New | 300 | $26 |
"% of holder's portfolio" is LYRA's weight in each manager's 13F, not the share of Lyra Therapeutics Inc. the manager owns.